As of Aug 30
| -0.08 / -0.25%|
The 9 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 45.00, with a high estimate of 60.00 and a low estimate of 39.00. The median estimate represents a +38.29% increase from the last price of 32.54.
The current consensus among 9 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.